CBNB (Chemical Business NewsBase)
Subject
CoverageNews affecting the chemical industry:• Company information• Products and production• Market information• Environmental aspects• Legal aspects and regulations

File Type

BibliographicFeatures

Thesaurus

NoneAlerts (SDIs)

WeeklyCAS Registry
Number® Identifiers

SLART

Keep & Share

Structures



RecordContent• Records contain bibliographic information, controlled indexing for company andcountry names, chemical names and important concepts, CAS Registry Numbers®,
and an abstract.

File Size• More than 2.0 million records (08/2022)

Coverage

1984-presentUpdates

Daily

LanguageEnglish

Database
Producer

Elsevier Engineering Information Inc.
1 Castle Point Terrace
Hoboken, New Jersey 07030-5996
USAPhone: +1 201 216-8500
Fax: +1 201 216-8532
Email: eicustomersupport@elsevier.com
Copyright Holder

August 2022

2
CBNB

Sources

User Aids

Cluster

August 2022

•
•
•
•
•
•

Newspapers
JournalsCompany reports
Stockbroker reports
Market research reports
Books

••
•
•
•

Press releases
Trade literature
Advertisements
Government and EU publications
Directories• Online Helps (HELP DIRECTORY lists all help messages available)• STNGUIDE• AGRICULTURE• ALLBIB• BUSINESS• CASRNS• CHEMENG• CHEMISTRY• COMPANIES• ENVIRONMENT• FUELS• GOVREGS• HEALTH• MATERIALS• PETROLEUM• PHARMACOLOGY• POLYMERSSTN Database Cluster information:
http://www.stn-international.com/en/customersupport/customersupport#cluster+%7C+subjects+%7C+features

3
CBNB

Search and Display Field Codes
Fields that allow left truncation are indicated by an asterisk (*).

General Search Fields
Search Field NameSearch
CodeDisplay
Codes

Search Examples

Basic Index* (contains single
words from the title (TI)*,abstract (AB)*, classification
code (CC), corporate name(CO), geographical term (GT),controlled term (CT), andchemical name (CN) fields, aswell as CAS Registry Numbers)

Noneor(/BI)

S ICI AND KLEAS SPECIALITY CHEMICAL# AND SOUTH
AFRICAS 50-78-2
S ?TRIAZOL?

TI, AB, CC,CO, GT, CT,CN, RN

Accession Number/ANAN

Abstract*
Classification Code (1)

/AB
/CC

Chemical Name*/CN

Corporate Name (1)Controlled Term
Controlled Word
Document Number
Document Type(code and text)
Entry Date (2)/CO/CT/CW/DN/DT(or /TC)/ED(or /UP)/GT

S 3545040781/AN
S 0544032094/AN
S CONSUMER DEMAND/AB
S MS-19/CC
S SPECIALITY CHEMICALS/CC
S ASPIRIN/CNS DIETHYLENE GLYCOL/CNS ICI AUSTRALIA/COS PLANT CAPACITY/CTS PLANT CAPACITY/CW
S TCD3545040761
S JOURNAL/DT
S J/DTS ED>JAN 2008
S NORTH AMERICA/GT
S 21/GT
S 1-85056-091-9/ISN
S EKEPAB/ISN
S 0014-0058/ISN
S CHEMICAL MARKETING REPORTER/JTS GERMAN/LAS DE/LAS NOV 1989/PD
S 1999-2000/PY
S POLIS-954990605/RE
S 550-78-2/RN
S 2853/SIC
S 285/SIC
S 28/SIC
S COATINGS/SIC
S CHEMICAL WEEK/SO AND DEC 1989/SOS HOECHST ANNUAL REPORT/SOGTS CFC REPLACEMENT#/TI

TI

Geographic Term(code and text)
International Standard(Document) Number(CODEN, ISBN, and ISSN)
Journal Title
Language(ISO code and text)
Publication Date (2)Publication Year (2)Reference
CAS Registry Number
Standard Industrial(Classification) Code(code and text) (1)
Source (contains journal title andother higher level titles, ISBN,ISSN, CODEN, publishing
information)
Title*/ISN/JT/LA/PD/PY/RE/RN/SIC/SO/TIAB
CCCNCOCTCTDNDTED

ISN, SOJT, SO
LAPD, SO
PY, PD, SO
RE
RN
SIC

SO

(1) Searching with implied (S) proximity is available in this field.
(2) Numeric search field that may be searched using numeric operators or ranges.

August 2022

4CBNBDISPLAY and PRINT Formats
Any combination of formats may be used to display or print answers. Multiple codes must be separated byspaces or commas, e.g., D L1 1-5 TI CO. The fields are displayed or printed in the order requested.
Hit-term highlighting is available for all fields. Highlighting must be ON during SEARCH to use the HIT, KWIC,
and OCC formats.
FormatContent

Examples

ABANCCCN
COCT
DN
DT (TC)GTISN (1)
JT (1)LA
PD (1)PY (1)
RERN
SIC
SOTI

AbstractAccession Number
Classification Code
Chemical Name
Corporate NameControlled Term
Document Number
Document Type
Geographic Term
International Standard (Document) Number
Journal Title
Language
Publication Date
Publication Year
Reference
CAS Registry Number
Standard Industrial (Classification) CodeSourceTitle

D TI ABD 1-5 AND CC CTD CN
D CO
D CT CC
D DN
D DT LA
D GT
D ISN
D JT
D LA
D PD
D PY
D RED RN 1-3
D SIC
D L5 SO
D TI 1-10

ABS
ALL
IALLBIBIBIB
IND
SCAN (2)
TRIAL (TRI, SAMPLE,SAM, FREE)

AN, AB, RE
BIB, AB, RE, CC, GT, CT, CN, RN, SIC, CO
ALL, indented with text labels
AN, TI, SO, DT, LA, AV, ED
BIB, indented with text labels
AN, DN, CC, GT, CT, CN, RN, SIC, CO
TI, CC, GT, CT, RN, CO (random display without answer numbers)
AN, TI, CC, GT, CT, RN, CO

D ABS
D ALL 1-10
D IALLD BIB
D IBIBD L5 INDD SCAN
D TRI

HIT
KWIC
OCCHit term(s) and field(s)Up to 50 words before and after hit term(s) (KeyWord-In-Context)
Number of occurrences of hit term(s) and field(s) in which they occur

D HIT
D KWIC
D OCC(1) Custom display only.
(2) SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.

SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in ananswer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in ananswer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of thespecified field(s).

August 2022

5CBNB

SELECT, ANALYZE, and SORT Fields (cont'd)
Field Name
Abstract
Accession Number
Classification Code
Chemical Name
Corporate Name
CODEN
Controlled Term
Document Type
Geographic Term
International Standard Book Number
International Standard (Document) Number
International Standard Serial Number
Journal Title
Publication Date
Publication Year
Reference
CAS Registry Number
Standard Industrial (Classification) CodeSourceTitle

Field CodeABANCCCNCOCODEN
CTDT (TC)GTISBNISN
ISSN
JTPD
PY
RERN
SIC
SOTI

ANALYZE/SELECT (1)SORTY (2)YYYYNYYYNY (3)NY
YY (4)YYYY (5)Y (default)

NNYYYYNYYYNY
YYYNYYNY(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HITTI.
(2) Appends /BI to the terms created by SELECT.
(3) Selects or analyzes ISSN, ISBN, and CODEN with /ISN appended to the terms created by SELECT.
(4) SELECT HIT and ANALYZE HIT are not valid with this field.
(5) Selects or analyzes ISSN, ISBN, and CODEN with /SO appended to the terms created by SELECT.

Sample Records
DISPLAY ALL OF JOURNAL
AN3545040761
CBNB
DN
TCD3545040761
TI
Opinion/decision on a Paediatric investigation plan (PIP): Synthetic
double-stranded siRNA oligonucleotide directed against antithrombin mRNAand covalently linked to a ligand containing three N-acetylgalactosamine
residues (fitusiran), P: decision agreeing on a investigation plan, withor without partial waiver(s) and or deferral(s), P/0186/2019(EMEA-001855-PIP01-15).
SO
EMA (European Medicines Agency) (Oct 2019), 1-10, (900 plus words)
DT
Journal; (Overview)
LA
EnglishAV
Website: http://www.ema.europa.eu
EDEntered STN: 8 Nov 2019
Last updated on STN: 8 Nov 2019AB
On 29 Oct 2019, the European Medicines Agency published decision
P/0186/2019 of 15 May 2019 on the agreement of a paediatricinvestigation plan and on the granting of a deferral and on the grantingof a waiver for synthetic double-stranded siRNA oligonucleotide directedagainst antithrombin mRNA and covalently linked to a ligand containing
three N-acetylgalactosamine residues (fitusiran) (EMEA-001855-PIP01-15).
A paediatric investigation plan for synthetic double-stranded siRNAoligonucleotide directed against antithrombin mRNA and covalently linked
to a ligand containing three N-acetylgalactosamine residues (fitusiran),solution for injection, subcutaneous use, the details of which are set
out in the opinion of the Paediatric Committee of the European Medicines
August 2022

6CBNBCCGTCTCNSICCOAgency annexed hereto, together with its appendices, is hereby agreed. A
deferral for synthetic double-stranded siRNA oligonucleotide directedagainst antithrombin mRNA and covalently linked to a ligand containing
three N-acetylgalactosamine residues (fitusiran), solution for
injection, subcutaneous use, the details of which are set out in theopinion of the Paediatric Committee of the European Medicines Agency
annexed hereto, together with its appendices, is hereby granted. A
waiver for synthetic double-stranded siRNA oligonucleotide directedagainst antithrombin mRNA and covalently linked to a ligand containing
three N-acetylgalactosamine residues (fitusiran), solution forinjection, subcutaneous use, the details of which are set out in theopinion of the Paediatric Committee of the European Medicines Agency
annexed hereto, together with its appendices, is hereby granted. Thisdecision is addressed to Genzyme Europe BV, Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands. Indication(s): Treatment of congenital
haemophilia; and a treatment of congenital haemophilia B. The Norwegian
Paediatric Committee member agrees with the above-mentionedrecommendation of the Paediatric Committee. Original Source: EMA:
EMA/256057/2019: European Medicines Agency decision P/0186/2019 of 15
May 2019 on the agreement of a paediatric investigation plan and on thegranting of a deferral and on the granting of a waiver for synthetic
double-stranded siRNA oligonucleotide directed against antithrombin mRNAand covalently linked to a ligand containing three N-acetylgalactosamine
residues (fitusiran) (EMEA-001855-PIP01-15) in accordance withRegulation (EC) No 1901/2006 of the European Parliament and of theCouncil; https://www.ema.europa.eu/documents/pip-decision/p/0186/2019ema-decision-15-may-2019-agreement-pip-granting-deferral-waiversynthetic-double-stranded-sirna_en.pdf; 15 May 2019.
MS-04 Pharmaceuticals Prosthetics and Medical Chemistry; LA-40 Permits
and Patents; MS-21 Biotechnology
1110 European Union
regulations and rulings
oligonucleotides; ligands; haemophilia B treatments; haemophiliatreatments; fitusiran2836 Biological Products; 2899 Chemical Products NEC; 28341
Cardiovascular Preparations
Genzyme Europe

DISPLAY ALL OF PRESS RELEASE
AN2647064544
CBNB
DN
TCD2647064544
TIPotash One agrees to friendly takeover by K+S for C$4.50 per share incash.
SO(22 Nov 2010), (200-899 words)
DT
Press Release; (Column)
LA
EnglishAV
K+S AG, Bertha-von-Suttner-Strasse 7, 34131 Kassel, Germany, tel: +495619 3010, fax: +49 5619 30117 53, website: www.k-plus-s.com
ED
Entered STN: 5 Jan 2016
Last updated on STN: 14 Mar 2017AB
On 22 Nov 2010, K+S AG and Potash One Inc announced that they haveentered into a Support Agreement pursuant to which K+S will make anoffer to acquire all of the issued and outstanding common shares ofPotash One at a price of C$4.50 per share in cash for total
consideration of approximately C$434 M (EUR 311 M). The offer represents
a: 24.3% premium to the closing price of Potash One shares on 19 Nov
2010 on the Toronto Stock Exchange; 31.3% premium over the 10-day
weighted average trading price of the shares up to and including 19 Nov
August 2022

7CBNBCCGTCTCNRN
SIC
CO2010; and 82.2% premium to Potash One's share price of CAD 2.47 on 16Aug 2010, the day prior to Potash Corp's rejection of BHP Billiton's
unsolicited proposal. The Potash One Board of Directors has unanimously
determined that the transaction is fair to Potash One shareholders andis in the best interests of the company and its shareholders. The Board
recommends that shareholders tender their common shares to the offer.
Potash One's Board has received an opinion from GMP Securities L.P. thatthe consideration to be received by the Potash One shareholders under
the offer is fair from a financial point of view to those shareholders.
Potash One holds several potash exploration licenses in the Canadianprovince of Saskatchewan, including the Legacy Project, an advanced
greenfield project to develop a potash solution mine. K+S estimates
production capacity of up to 2.7 M tonnes/y of potassium chloride. The
realisation of this production capacity would represent an approximately$2.5 bn capital investment into Saskatchewan and create up to 300
highly-skilled jobs. The project headquarters will be located in
Saskatchewan, Canada. K+S expects initial production no earlier than2015.
MS-06 Fertilizers
1112 Germany; 2103 Canadamergers and acquisitions; investment; plant capacity; employment
potassium chloride
7447-40-7
28194 Potassium and Sodium Compounds
Kali und Salz (K+S); Potash One

In North America

In EMEAIn Japan

CAS Customer Center
P.O. Box 3012
Columbus, Ohio 43210-0012
U.S.A.

CAS Customer Center EMEA
(represented by FIZ Karlsruhe)
P.O. Box 2465
76012 Karlsruhe
Germany

JAICI (Japan Association forInternational Chemical Information)
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021
Japan

Phone:

800-753-4227 (North America)
614-447-3731 (worldwide)
Email:
help@cas.org
Internet: www.cas.org

Phone: +49-7247-808-555
E-mail: EMEAhelp@cas.org

Phone:+81-3-5978-3601 (Technical Service)+81-3-5978-3621 (Customer Service)support@jaici.or.jp (Technical Service)customer@jaici.or.jp (Customer Service)
Internet: www.jaici.or.jp
Email:

August 2022